287 related articles for article (PubMed ID: 16291467)
1. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.
Boutron I; Moher D; Tugwell P; Giraudeau B; Poiraudeau S; Nizard R; Ravaud P
J Clin Epidemiol; 2005 Dec; 58(12):1233-40. PubMed ID: 16291467
[TBL] [Abstract][Full Text] [Related]
2. A checklist to assess the quality of reports on spa therapy and balneotherapy trials was developed using the Delphi consensus method: the SPAC checklist.
Kamioka H; Kawamura Y; Tsutani K; Maeda M; Hayasaka S; Okuizum H; Okada S; Honda T; Iijima Y
Complement Ther Med; 2013 Aug; 21(4):324-32. PubMed ID: 23876563
[TBL] [Abstract][Full Text] [Related]
3. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected].
Gagnier J; Boon H; Rochon P; Barnes J; Moher D; Bombardier C;
Explore (NY); 2006 Mar; 2(2):143-9. PubMed ID: 16781628
[TBL] [Abstract][Full Text] [Related]
4. Applicability and clinical relevance of results in randomized controlled trials: the Cochrane review on exercise therapy for low back pain as an example.
Malmivaara A; Koes BW; Bouter LM; van Tulder MW
Spine (Phila Pa 1976); 2006 Jun; 31(13):1405-9. PubMed ID: 16741446
[TBL] [Abstract][Full Text] [Related]
5. A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative.
Meyer E; Delaney M; Lin Y; Morris A; Pavenski K; Tinmouth A; Murphy M; Slichter SJ; Heddle N; Dumont LJ
Transfusion; 2013 Jun; 53(6):1328-34. PubMed ID: 23003345
[TBL] [Abstract][Full Text] [Related]
6. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group.
Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
Br J Surg; 2000 Nov; 87(11):1448-54. PubMed ID: 11091231
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
8. [Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM Statement].
Moher D; Cook DJ; Eastwood S; Olkin I; Rennie D; Stroup DF
Rev Esp Salud Publica; 2000; 74(2):107-18. PubMed ID: 10918802
[TBL] [Abstract][Full Text] [Related]
9. Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments.
Mokkink LB; Terwee CB; Knol DL; Stratford PW; Alonso J; Patrick DL; Bouter LM; de Vet HC
BMC Med Res Methodol; 2006 Jan; 6():2. PubMed ID: 16433905
[TBL] [Abstract][Full Text] [Related]
10. Development of a Quality Checklist Using Delphi Methods for Prescriptive Clinical Prediction Rules: the QUADCPR.
Cook C; Brismée JM; Pietrobon R; Sizer P; Hegedus E; Riddle DL
J Manipulative Physiol Ther; 2010 Jan; 33(1):29-41. PubMed ID: 20114098
[TBL] [Abstract][Full Text] [Related]
11. Primer: assessing the efficacy and safety of nonpharmacologic treatments for chronic rheumatic diseases.
Ravaud P; Boutron I
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):313-9. PubMed ID: 16932710
[TBL] [Abstract][Full Text] [Related]
12. Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors.
Peng X; Zhao Y; Liang X; Wu L; Cui S; Guo A; Wang W
Contemp Clin Trials; 2006 Feb; 27(1):70-82. PubMed ID: 16243588
[TBL] [Abstract][Full Text] [Related]
13. Do standards for the design and reporting of nonpharmacological trials facilitate hypnotherapy studies?
Marc I; Pelland-Marcotte MC; Ernst E
Int J Clin Exp Hypn; 2011 Jan; 59(1):64-81. PubMed ID: 21104485
[TBL] [Abstract][Full Text] [Related]
14. Assessing the reporting and scientific quality of meta-analyses of randomized controlled trials of treatments for anxiety disorders.
Bereza BG; Machado M; Einarson TR
Ann Pharmacother; 2008 Oct; 42(10):1402-9. PubMed ID: 18728102
[TBL] [Abstract][Full Text] [Related]
15. A review of blinding in randomized controlled trials found results inconsistent and questionable.
Boutron I; Estellat C; Ravaud P
J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
[TBL] [Abstract][Full Text] [Related]
16. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
Boutron I; Tubach F; Giraudeau B; Ravaud P
J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
[TBL] [Abstract][Full Text] [Related]
17. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
Chan S; Bhandari M
J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
[TBL] [Abstract][Full Text] [Related]
18. Does a "Level I Evidence" rating imply high quality of reporting in orthopaedic randomised controlled trials?
Poolman RW; Struijs PA; Krips R; Sierevelt IN; Lutz KH; Bhandari M
BMC Med Res Methodol; 2006 Sep; 6():44. PubMed ID: 16965628
[TBL] [Abstract][Full Text] [Related]
19. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria.
Evers S; Goossens M; de Vet H; van Tulder M; Ament A
Int J Technol Assess Health Care; 2005; 21(2):240-5. PubMed ID: 15921065
[TBL] [Abstract][Full Text] [Related]
20. The reporting quality of meta-analyses improves: a random sampling study.
Wen J; Ren Y; Wang L; Li Y; Liu Y; Zhou M; Liu P; Ye L; Li Y; Tian W
J Clin Epidemiol; 2008 Aug; 61(8):770-5. PubMed ID: 18411041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
